Argentum and the CDC recently shared the following information about the Omicron variant, which has been confirmed in several states including California, New Jersey, Missouri, and Pennsylvania.
The FDA issued a statement on its investigation and action on the Omicron variant. The statement includes links to updated information on use and limitations of monoclonal antibodies, fact sheets on variants and therapeutics, and testing and variants.
PO Box 232, LaGrange, KY 40031
Phone: 502.938.5102